Borbulevych O.Y., K.H. Piepenbrink, B.E. Gloor, D.R. Scott, R.F. Sommese D.K. Cole, A.K. Sewell, and B.M. Baker (2009) T cell receptor crossreactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity. 2009 31, 885-96.
Archbold J.K., W.A. Macdonald, S. Gras S, L.K. Ely, J.J. Miles, M.J. Bell, R.M. Brennan, T. Beddoe, M.C. Wilce, C.S. Clements, A.W. Purcell, J. McCluskey, S.R. Burrows and Rossjohn (2009). Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. Journal of Experimental Medicine, 206, 209-19.
Melenhorst J.J., P. Scheinberg, P.K. Chattopadhyay, E. Gostick, K. Ladell, M. Roederer, N.F. Hensel, D.C Douek, A.J. Barrett and D.A. Price (2009). High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow. Blood, 113, 2238-44.
Venturi V, D.A. Price, D.C Douek and M.P. Davenport (2008). The molecular basis for public T-cell responses? Nature Reviews Immunology 8, 231-8.
Varela-Rohena, A., P.E. Molloy, S. M. Dunn, Y. Li, M. M. Suhoski, R.G. Carroll, A. Milicic, T. Mahon, D.H. Sutton, B.E. Laugel, R. Moysey, B.J. Cameron, A. Vuidepot, M.E. Purbhoo, D.K. Cole, R.E. Phillips, C.H. June, B.K. Jakobsen, J.L. Riley* and A.K. Sewell* (2008) Control of HIV-1 immune escape by CD8 T-cells expressing enhanced T-cell receptor (*equal contribution) Nature Medicine 14, 1390-5.
Appay V, D.C. Douek and D.A. Price (2008) CD8+ T cell efficacy in vaccination and disease. Nature Medicine 14, 623-8.
Skowera, A., R.J. Elps, R. Varela-Calvino, S. Arif, G.C. Huang, C. Van-Krinks, A. Zaremba, C. Rackham, J.S. Allen, T.I. Tree, M. Zhao, M. C.M. Dayan, A.K. Sewell, W. Unger, J.W. Drijfhout, F. Ossendorp, B.O. Roep and M. Peakman (2008) CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. Journal of Clinical Investigation, 118, 3390-3402.
Kasprowicz, V. S.M. Ward, A. Turner, A. Grammatikos, B. Nolan, L. Lewis-Ximenez, C. Sharp, J. Woodruff, V. Fleming, S. Sims, B.D. Walker, A. Sewell, G M. Lauer and P Klenerman (2008). Defining the directionalty and quality of CD8+ T cell heterologous immunity in hepatitis C virus infection. Journal of Clinical Investigation, 118, 1143-53.
Jo, J., U Aichelle, N. Kersting, R. Klein, P. Aichele, E. Bisse, A. K Sewell, H.E. Blum, R. Bartenschlager, V. Lohmann and R. Thimme (2009) Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology, 136, 1391-401.
Wynn K.K., Z. Fulton, L. Cooper, S.L. Silins, S. Gras, J.K. Archbold, E.E. Tynan, J.J. Miles, J. McCluskey, S.R. Burrows, J. Rossjohn, and R. Khanna R (2008). Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood, 111, 4283-92.